"10.1371_journal.pone.0060147","plos one","2013-04-03T00:00:00Z","Ian Mcgowan; Craig Hoesley; Ross D Cranston; Philip Andrew; Laura Janocko; James Y Dai; Alex Carballo-Dieguez; Ratiya Kunjara Na Ayudhya; Jeanna Piper; Florian Hladik; Ken Mayer","University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Microbicide Trials Network, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America; University of Alabama, Birmingham, Alabama, United States of America; FHI 360, Research Triangle Park, Durham, North Carolina, United States of America; University of Washington, Seattle, Washington, United States of America; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Columbia University, New York, New York, United States of America; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Fenway Health, Boston, Massachusetts, United States of America","Conceived and designed the experiments: IM CH RDC PA LJ JYD AC-D JP FH KM. Performed the experiments: IM CH RDC PA KM LJ RKNA FH. Analyzed the data: JYD AC-D FH. Contributed reagents/materials/analysis tools: AC-D FH. Wrote the paper: IM CH RDC LJ JYD AC-D JP FH KM.","CONRAD provided regulatory support for the tenofovir gel IND given their ongoing management of tenofovir gel development and held the IND for the tenofovir gel in this study. However, CONRAD did not provide financial support for the study. MTN paid for the tenofovir gel. Finally, there are no restrictions to data from MTN-007 which is controlled by CONRAD. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Ian Mcgowan","IM",11,TRUE,10,8,3,9,TRUE,FALSE,FALSE,0,NA,FALSE
